These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


393 related items for PubMed ID: 23782845

  • 1. Comparison of four skin preparation strategies to prevent catheter-related infection in intensive care unit (CLEAN trial): a study protocol for a randomized controlled trial.
    Goudet V, Timsit JF, Lucet JC, Lepape A, Balayn D, Seguin S, Mimoz O.
    Trials; 2013 Apr 27; 14():114. PubMed ID: 23782845
    [Abstract] [Full Text] [Related]

  • 2. Skin antisepsis with chlorhexidine-alcohol versus povidone iodine-alcohol, with and without skin scrubbing, for prevention of intravascular-catheter-related infection (CLEAN): an open-label, multicentre, randomised, controlled, two-by-two factorial trial.
    Mimoz O, Lucet JC, Kerforne T, Pascal J, Souweine B, Goudet V, Mercat A, Bouadma L, Lasocki S, Alfandari S, Friggeri A, Wallet F, Allou N, Ruckly S, Balayn D, Lepape A, Timsit JF, CLEAN trial investigators.
    Lancet; 2015 Nov 21; 386(10008):2069-2077. PubMed ID: 26388532
    [Abstract] [Full Text] [Related]

  • 3. Skin antisepsis for reducing central venous catheter-related infections.
    Lai NM, Lai NA, O'Riordan E, Chaiyakunapruk N, Taylor JE, Tan K.
    Cochrane Database Syst Rev; 2016 Jul 13; 7(7):CD010140. PubMed ID: 27410189
    [Abstract] [Full Text] [Related]

  • 4. Chlorhexidine plus alcohol versus povidone iodine plus alcohol, combined or not with innovative devices, for prevention of short-term peripheral venous catheter infection and failure (CLEAN 3 study): an investigator-initiated, open-label, single centre, randomised-controlled, two-by-two factorial trial.
    Guenezan J, Marjanovic N, Drugeon B, Neill RO, Liuu E, Roblot F, Palazzo P, Bironneau V, Prevost F, Paul J, Pichon M, Boisson M, Frasca D, Mimoz O, CLEAN-3 trial investigators.
    Lancet Infect Dis; 2021 Jul 13; 21(7):1038-1048. PubMed ID: 33539734
    [Abstract] [Full Text] [Related]

  • 5. Skin antisepsis with chlorhexidine-alcohol versus povidone iodine-alcohol, combined or not with use of a bundle of new devices, for prevention of short-term peripheral venous catheter-related infectious complications and catheter failure: an open-label, single-centre, randomised, four-parallel group, two-by-two factorial trial: CLEAN 3 protocol study.
    Guenezan J, Drugeon B, O'Neill R, Caillaud D, Sénamaud C, Pouzet C, Seguin S, Frasca D, Mimoz O.
    BMJ Open; 2019 Apr 02; 9(4):e028549. PubMed ID: 30944142
    [Abstract] [Full Text] [Related]

  • 6. Alcoholic povidone-iodine to prevent central venous catheter colonization: A randomized unit-crossover study.
    Parienti JJ, du Cheyron D, Ramakers M, Malbruny B, Leclercq R, Le Coutour X, Charbonneau P, Members of the NACRE Study Group.
    Crit Care Med; 2004 Mar 02; 32(3):708-13. PubMed ID: 15090951
    [Abstract] [Full Text] [Related]

  • 7. Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters.
    Maki DG, Ringer M, Alvarado CJ.
    Lancet; 1991 Aug 10; 338(8763):339-43. PubMed ID: 1677698
    [Abstract] [Full Text] [Related]

  • 8. Comparison of alcoholic chlorhexidine and povidone-iodine cutaneous antiseptics for the prevention of central venous catheter-related infection: a cohort and quasi-experimental multicenter study.
    Pages J, Hazera P, Mégarbane B, du Cheyron D, Thuong M, Dutheil JJ, Valette X, Fournel F, Mermel LA, Mira JP, Daubin C, Parienti JJ, 3SITES Study Group.
    Intensive Care Med; 2016 Sep 10; 42(9):1418-26. PubMed ID: 27311311
    [Abstract] [Full Text] [Related]

  • 9. Safety and efficacy of 2% chlorhexidine gluconate aqueous versus 2% chlorhexidine gluconate in 70% isopropyl alcohol for skin disinfection prior to percutaneous central venous catheter insertion in preterm neonates: the ARCTIC randomised-controlled feasibility trial protocol.
    Clarke P, Craig JV, Wain J, Tremlett C, Linsell L, Bowler U, Juszczak E, Heath PT.
    BMJ Open; 2019 Feb 19; 9(2):e028022. PubMed ID: 30782955
    [Abstract] [Full Text] [Related]

  • 10. Prospective, randomized trial of two antiseptic solutions for prevention of central venous or arterial catheter colonization and infection in intensive care unit patients.
    Mimoz O, Pieroni L, Lawrence C, Edouard A, Costa Y, Samii K, Brun-Buisson C.
    Crit Care Med; 1996 Nov 19; 24(11):1818-23. PubMed ID: 8917031
    [Abstract] [Full Text] [Related]

  • 11. Prospective randomized trial of 3 antiseptic solutions for prevention of catheter colonization in an intensive care unit for adult patients.
    Vallés J, Fernández I, Alcaraz D, Chacón E, Cazorla A, Canals M, Mariscal D, Fontanals D, Morón A.
    Infect Control Hosp Epidemiol; 2008 Sep 19; 29(9):847-53. PubMed ID: 18665819
    [Abstract] [Full Text] [Related]

  • 12. Chlorhexidine versus povidone iodine in preventing colonization of continuous epidural catheters in children: a randomized, controlled trial.
    Kinirons B, Mimoz O, Lafendi L, Naas T, Meunier J, Nordmann P.
    Anesthesiology; 2001 Feb 19; 94(2):239-44. PubMed ID: 11176087
    [Abstract] [Full Text] [Related]

  • 13. Comparison of 10% povidone-iodine and 0.5% chlorhexidine gluconate for the prevention of peripheral intravenous catheter colonization in neonates: a prospective trial.
    Garland JS, Buck RK, Maloney P, Durkin DM, Toth-Lloyd S, Duffy M, Szocik P, McAuliffe TL, Goldmann D.
    Pediatr Infect Dis J; 1995 Jun 19; 14(6):510-6. PubMed ID: 7667056
    [Abstract] [Full Text] [Related]

  • 14. 2% chlorhexidine-70% isopropyl alcohol versus 10% povidone-iodine for insertion site cleaning before central line insertion in preterm infants: a randomised trial.
    Kieran EA, O'Sullivan A, Miletin J, Twomey AR, Knowles SJ, O'Donnell CPF.
    Arch Dis Child Fetal Neonatal Ed; 2018 Mar 19; 103(2):F101-F106. PubMed ID: 29074717
    [Abstract] [Full Text] [Related]

  • 15. Skin disinfection before epidural catheterization: comparative study of povidone-iodine versus chlorhexidine ethanol.
    Kasuda H, Fukuda H, Togashi H, Hotta K, Hirai Y, Hayashi M.
    Dermatology; 2002 Mar 19; 204 Suppl 1():42-6. PubMed ID: 12011520
    [Abstract] [Full Text] [Related]

  • 16. Prospective randomized trial of 10% povidone-iodine versus 0.5% tincture of chlorhexidine as cutaneous antisepsis for prevention of central venous catheter infection.
    Humar A, Ostromecki A, Direnfeld J, Marshall JC, Lazar N, Houston PC, Boiteau P, Conly JM.
    Clin Infect Dis; 2000 Oct 19; 31(4):1001-7. PubMed ID: 11049783
    [Abstract] [Full Text] [Related]

  • 17. Multicentre, open-label, randomised, controlled clinical trial comparing 2% chlorhexidine-70% isopropanol and 5% povidone iodine-69% ethanol for skin antisepsis in reducing surgical-site infection after cardiac surgery: the CLEAN 2 study protocol.
    Boisson M, Corbi P, Kerforne T, Camilleri L, Debauchez M, Demondion P, Eljezi V, Flecher E, Lepelletier D, Leprince P, Nesseler N, Nizou JY, Roussel JC, Rozec B, Ruckly S, Lucet JC, Timsit JF, Mimoz O.
    BMJ Open; 2019 Jun 17; 9(6):e026929. PubMed ID: 31213447
    [Abstract] [Full Text] [Related]

  • 18. A randomized trial comparing povidone-iodine to a chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infections in neonates.
    Garland JS, Alex CP, Mueller CD, Otten D, Shivpuri C, Harris MC, Naples M, Pellegrini J, Buck RK, McAuliffe TL, Goldmann DA, Maki DG.
    Pediatrics; 2001 Jun 17; 107(6):1431-6. PubMed ID: 11389271
    [Abstract] [Full Text] [Related]

  • 19. Sequential use of povidone-iodine and chlorhexidine for cutaneous antisepsis: A systematic review.
    Mermel LA.
    Infect Control Hosp Epidemiol; 2020 Jan 17; 41(1):98-101. PubMed ID: 31619301
    [Abstract] [Full Text] [Related]

  • 20. Combined skin disinfection with chlorhexidine/propanol and aqueous povidone-iodine reduces bacterial colonisation of central venous catheters.
    Langgartner J, Linde HJ, Lehn N, Reng M, Schölmerich J, Glück T.
    Intensive Care Med; 2004 Jun 17; 30(6):1081-8. PubMed ID: 15085323
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 20.